BioSpace News Archive

BioCapital

Novel cell therapy treatments offer promise to immune-compromised children

In a first-of-its-kind clinical trial, researchers found that intravenous therapies made from virus-specific T-cells can effectively treat immunocompromised pediatric patients, far surpassing the current standard of care, according to new research published in Nature Communications.

April 18, 2024
·
5 min read
Business

AIxMed and CorePlus Partner to study a Urine Cytology Workflow Solution

AIxMed, innovators and providers of an AI-powered computational platform for cytology applications, and CorePlus a leader in precision pathology have entered into an agreement to conduct a pilot study applying the AIxMed’s AI algorithm to test a workflow solution for urine cytology.

April 18, 2024
·
2 min read
Lone Star Bio

Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Bio-Path Holdings, Inc. announced that it has entered into a definitive agreement with certain institutional investors for the issuance and sale of 375,000 shares of its common stock at a purchase price per share of $3.225 in a registered direct offering priced at-the-market under Nasdaq rules.

April 18, 2024
·
6 min read
Business

Computational Biology Pioneer Katie Pollard Elected as AAAS Fellow

The American Association for the Advancement of Science, one of the world’s largest general scientific societies, has elected Gladstone Senior Investigator Katie Pollard, PhD, into its new class of AAAS Fellows, a lifetime honor within the scientific community.

April 18, 2024
·
4 min read
BioMidwest

GE HealthCare Introduces AI-Enhanced Voluson Signature 20 and 18 Ultrasound Systems to Advance Women’s Health Imaging

GE HealthCare announced the launch of the Voluson Signature 20 and 18 ultrasound systems, which comprehensively integrate artificial intelligence, advanced tools and an ergonomic design to speed exam time for clinicians while delivering a clearer picture of various conditions impacting women’s health.

April 18, 2024
·
4 min read
Genetown

Gilead Sciences Publishes 2023 ESG Impact Report

Gilead Sciences published its 2023 Environmental, Social and Governance (ESG) Impact Report, which uses the ESG framework to highlight the successes and achievements of the prior year.

April 18, 2024
·
1 min read
Pharm Country

New Study from HSS Reveals Minimally Invasive Procedure Can Delay Arthritis in Select Patients with Hip Impingement

A new study by surgeon-scientists at Hospital for Special Surgery (HSS) found that 25% of patients with hip impingement who underwent modern arthroscopy for their condition experienced a delay in the natural progression of osteoarthritis.

April 18, 2024
·
6 min read